News

News

Medi-Lynx Cardiac Monitoring LLC and Medicalgorithmics have announced their participation in a research project investigating the impact of lifestyle modification on ablation outcome in atrial...

Symphony Health Solutions (SHS) and the American College of Cardiology announced the completion of a new research platform. The HIPAA-compliant platform combines anonymized patient-level data from...

Covidien, Trellis peripheral infusion system, FDA recall, balloon inflation port

A manufacturing error caused the balloon inflation ports to be mislabeled on Covidien’s Trellis 6 and Trellis 8 Peripheral Infusion systems, prompting a U.S. Food and Drug Administration (FDA)...

Fantom, Reva Medical, Rutgers, bioresorbable stents

A new stent for treating cardiovascular disease that incorporates a polymer invented at Rutgers, The State University of New Jersey, has been implanted in patients for the first time.

Renal denervation, hypertension, Peregrine System

Ablative Solutions Inc. announced the addition of Michael Weber, M.D., FACP, FACC, FAHA, to its Scientific Advisory Board. 

Clinical trial/study

What should doctors wear? And how does something as simple as their choice of a suit, scrubs or slacks influence how patients view them?

Sudden cardiac arrest, resuscitation devices, AutoPulse, ZOLL

Zoll Medical Corporation, a manufacturer of medical devices and related software solutions, announced that RAV Gelderland-Midden in the Netherlands has equipped its fleet of 20 ambulances with the...

Bayer HealthCare’s Mark 7 Arterion angiographic contrast injector

There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives....

Advanced visualization (AV) software and clinical applications are essential in the interpretation workflow of computed tomography (CT) and magnetic resonance imaging (MRI). In the last few years...

Here are my predictions for technologies to watch in the coming year that have the potential to fundamentally change the practice of cardiology:

Yale, CORE, IV fluids, diuretics, heart failure, study

Many patients hospitalized with severe heart failure are receiving potentially harmful treatment with intravenous fluids, a Yale-led study has found.

blood pressure, systolic, hypertension, younger adults, cardiovascular, risk

Younger adults with elevated systolic blood pressure have a higher risk for cardiovascular disease and coronary heart disease than those with normal blood pressure, according to a large long-...

Ablation system, atrial fibrillation, Medtronic Arctic Front Advance Cryoballoon

Medtronic announced the initiation of the Cryo4 Persistent AF (Cryoballoon Ablation for Early Persistent Atrial Fibrillation) clinical trial.

Heart failure, remote monitoring, CardioMEMS, St. Jude Medical

Swedish Medical Center is the first facility in the Rocky Mountain Region to implant a new miniaturized, wireless monitoring sensor to manage heart failure (HF).

AliveCor, Heart Monitor, atrial fibrillation, AF, ECG, Cleveland Clinic, study

Cleveland Clinic and AliveCor, Inc. announced the online publication of study results from Cleveland Clinic’s iTransmit Study, "Evaluating the Efficacy and Feasibility...

Corevalve, valve sizes

Medtronic announced CE (Conformité Européene) mark for the 26 and 29mm sizes of the CoreValve Evolut R System, a next-generation self-expanding valve for transcatheter aortic...

peripheral arterial disease, Atherectomy devices, ISET

Ensuring that patients with peripheral arterial disease (PAD) get tested and treated with minimally invasive endovascular therapy saves legs and lives suggests a study in which amputation rates...

Heart failure, MitraClip, International Symposium on Endovascular Therapy

A minimally invasive procedure to repair severe mitral valve regurgitation by clipping together the valve’s leaflets can improve function and quality of life and reduce the risk of hospitalization...

Case Western Reserve’s chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack.

Medtronic, In.Pact Admiral DCB, PAD, U.S. launch, drug-coated balloon

United States hospitals began using a new medical device from Medtronic plc  called the In.Pact Admiral drug-coated balloon (DCB) to treat patients with peripheral arterial disease (PAD) in...